T he development of coronary artery disease re- mains the leading cause of morbidity and mortality in the long-term survival of patients after cardiac transplantation.1-4 Despite intense basic and clinical investigations, the pathogenesis of this accelerated atherosclerotic process remains unclear, but a number of clinical and immunological factors have been implicated.5-10 These factors include cytomegalovirus seroconversion, diabetes, hypercholesterolemia, and histocompatibility mismatch. 6 The most plausible pathophysiological mechanism is the exposure of donor thickening that is angiographically silent can be detected by IVUS and that this occurs in a majority of patients after transplantation. However, the functional significance of this intimal thickening is not known.
Accumulating evidence suggests that the vascular endothelium becomes dysfunctional in the early stages of native coronary atherosclerosis.15" 6 Normal coronary arteries with intact endothelium vasodilate in response to the endothelium-dependent agonist acetylcholine, whereas atherosclerotic coronary arteries invariably vasoconstrict, demonstrating the presence of endothelial dysfunction.'7"8 Similar observations have been made in cardiac transplant patients, with a large proportion of patients showing endothelial dysfunction by the first year after transplantation even though angiographically the arteries appear smooth.'9 However, it is not clear whether this dysfunction is caused by the presence of angiographically silent intimal thickening or whether the dysfunction can occur in morphologically normal arteries. In this study, we investigated the relation between intimal thickening as evaluated by IVUS and endothelial function as tested by acetylcholine both early and late after transplantation. Our hypotheses are that (1) endothelial dysfunction occurs in the early stages of transplant coronary disease preceding structural changes as seen by IVUS and (2) the prevalence and severity of the intimal pathology increases with time and is associated with worsening endothelial function in those studied late after transplantation.
Methods

Patient Population
This is a cross-sectional study consisting of 44 cardiac transplant recipients who were studied once at routine annual evaluation (years 1 to 8) from April 1991 through February 1992. During this period, a total of 85 patients presented for annual evaluation. Forty-one patients were not studied because of the presence of significant peripheral vascular disease, failure to give informed consent, and logistic reasons in the catheterization laboratory. The clinical and angiographic characteristics of these 41 patients excluded were not different from those of the study group. Within the total cohort of study patients, 11 patients were studied at 1 year and 8 patients were studied at .5 years after transplantation. The data from these 19 patients were used for comparison between endothelial functional testing and structural assessment. All patients were treated with triple immunosuppression (cyclosporin, prednisone, and azathioprine), and no patients had ongoing rejection requiring treatment at the time of the study.
The clinical characteristics for each patient were obtained, including the ages of the recipient and donor, the diagnosis before transplantation, cardiac risk factors before transplantation, years after transplantation, ischemic time of the heart, cholesterol values at each annual evaluation and a mean cholesterol over that time period, posttransplantation hypertension or diabetes, medical treatment of hypercholesterolemia after transplantation, and the number of treated rejection episodes.
Study Protocol
Written informed consent was obtained from patients before the catheterization procedure in accordance with the guidelines established by the Committee for the Protection of Human Subjects. Long-acting vasoactive medications, including calcium channel blockers, 13-blockers, nitrates, and converting enzyme inhibitors, were discontinued for at least 18 hours before the catheterization. After diagnostic right and left heart catheterization and right ventricular biopsy, patients were eligible for the study if there were no stenoses >50% in the left anterior descending artery. The study protocol was performed in 44 patients, but in 2 patients the left anterior descending artery was felt to be too small for passage of the IVUS catheter, and in 2 patients no ultrasound images were obtained because of technical failure. The study population thus consisted of 40 patients (32 men and 8 women).
Intracoronary infusions. After an 8F guiding catheter was positioned in the left main artery and 10 000 units of heparin was infused, a 2.5F infusion catheter was advanced through the guiding catheter over a 0.014-in guide wire into the proximal portion of the left anterior descending artery. Serial intracoronary infusions were made according to an established protocol: (1) control infusion (dextrose 5% in water [D5W1); (2) serial 2.5-minute infusions of the endothelium-dependent vasodilator acetylcholine (Miochol, Iolab Pharmaceuticals, Claremont, Calif) with final estimated intracoronary concentrations of 10-8, 10', and 10-6 mol/L; (3) 5-minute recontrol infusion of D5W; and (4) 3-minute infusion of the endothelium-independent vasodilator nitroglycerin at 16 mg/min.17 During each infusion, the blood pressure, heart rate, and ECG were continuously monitored.
Quantitative coronary angiographic images were taken after each intervention by a previously validated method.20 A nonionic contrast medium (Omnipaque, Winthrop Laboratories, New York, NY) was injected into the left coronary artery at 7 mL/s for a total of 9 mL with a power injector (Medrad, Pittsburgh, Pa) to opacify the coronary artery. The study vessel was positioned in the center of the screen such that overlap of adjacent arteries was minimized.
IVUS. After the above infusion system was removed, the intracoronary imaging system was passed into the left anterior descending artery over a 0.014-in guide wire. Sublingual nitroglycerin (0.4 mg) was given before insertion of the catheter. The imaging system consisted of a 30 Francisco; Intravascular Ultrasound Research Group Software). Twelve of the total of 120 image positions (three images per patient x 40 patients) were of suboptimal quality and were not analyzable. The ultrasound images at each position were interpreted by two observers blinded to the results of the quantitative angiography. The observers had access to the S-VHS recording as well as the digitized image. The lumen/ intima interface was traced by planimetry, and if measurable intimal thickening was present, the outer border of the thickening was also planimetered (intima/media border, Fig 1) . The intimal thickening was measured at eight radial chords, and the maximal thickness was recorded. The angle subtended by the thickening (angle of atherosclerosis) and the major and minor diameters of the lumen were also measured. An index of intimal thickness was calculated as (intimal area)/(lumen+ intima area). The images were also analyzed qualitatively for the presence of calcium. The results of the three digitized frames at each position were averaged to obtain the data for that position. 
Results
Clinical Characteristics
The mean age of the 40 study patients was 46 years (range, 16 to 61 years), and the mean age of the donors was 27 years (range, 11 to 52 years). Patients were studied at a mean of 3.0 years (range, 1 to 8 years) after transplantation. The pretransplantation diagnosis was cardiomyopathy in 31 patients (77.5%) and coronary artery disease in 9 (22.5%). The pretransplantation cardiac risk factors included diabetes mellitus in 4 patients (10%), hypertension in 9 (22.5%), cigarette smoking in 18 (45%), and hypercholesterolemia in 9 (22.5%). After transplantation, 27 patients (67.5%) were on lovastatin for hypercholesterolemia, and 22 (55%) had hypertension requiring treatment. The mean cholesterol after transplantation for the group was 235+7 mg/dL. Four patients had noncritical stenoses, and 18 patients had minor irregularities on angiography.
IVUS
The majority of these patients had angiographically smooth coronary arteries, although 4 This study also demonstrated that preserved endothelial vasodilator function may be seen in patients surviving .5 years after transplantation who are well clinically, even in the presence of intimal thickening. Thus, our hypotheses that endothelial function would be worse in those coronary segments with increasing intimal thickening and that preservation of endothelial function would not be possible in these coronary segments is refuted in this transplant population. IVUS Both in vitro and in vivo studies have confirmed the utility of IVUS in the assessment of coronary pathological lesions. In native-vessel atherosclerosis, intimal pathological lesions as detected by IVUS were found to precede changes seen by coronary angiography.23 Similarly, several groups have shown that IVUS was more sensitive than angiography in the detection of intimal thickening in cardiac transplant patients. 13, 14, 24, 25 In contrast to a previous report showing that all patients at 1 year had at least minimal thickening,14 this study shows that only a minority of patients (3 of 11; 27%) or coronary segments (6 of 30; 20%) studied at 1 year demonstrated intimal pathological lesions. This difference is probably a result of the method of classification. In the previous study, patients were classified according to the most severe of four segments, which may overestimate the involvement on a per-patient basis. Thus, intimal disease may be present at year 1 after transplantation, but the degree of involvement is probably low. Not unexpectedly, the prevalence and severity of intimal thickening are found to increase over time after transplantation, as suggested by recent preliminary reports. 25.26 The present data also suggest that transplant coronary disease is a heterogeneous process. Early after transplantation, there is little if any thickening in the coronary vessels. With time, patchy thickening begins to develop throughout the vessel, with no preference for distal or proximal segments. As the disease progresses, all segments of the artery become involved. Routine angiography is unable to detect these changes (90% of the study population has smooth coronary arteries), responses, it must be remembered that this was a cross-sectional, not a longitudinal, study. It can be assumed that intimal thickening is a patchy and progressive process and that early endothelial dysfunction may be important in initiating the atherosclerotic process, but care must be taken in the interpretation. A longitudinal follow-up study of ultrasound appearance and acetylcholine responses currently under way will be helpful in clarifying these issues.
Conclusions
IVUS is a useful method of determining the extent of intimal pathological lesions that are not seen by angiography. Clinical factors, including the length of time after transplantation and pretransplantation hypercholesterolemia, are related to the degree of intimal thickening. Endothelial dysfunction may be seen before structural changes by IVUS, and the vasodilator function may be preserved even in those patients with concentric intimal thickening. This suggests that an episodic endothelial injury, most likely immune in nature, may lead over time to intimal thickening. Patients who are long-term survivors may have a favorable outcome despite intimal thickening because of preserved endothelial function. Future longitudinal studies using IVUS and endothelial function testing may help to further our understanding of the pathophysiology of accelerated atherosclerosis and define better means of earlier detection of this disease.
